Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GZMA |
| Upstream (Parents) |
|---|
| (<<) TRIM22 → GZMA |
| (<<) CCL5 → GZMA |
| (<<) FGL2 → GZMA |
| (<<) GIMAP4 → GZMA |
| Downstream (Children) |
|---|
| GZMA → BTN3A3 (>>) |
| GZMA → CXCR6 (>>) |
| GZMA → PRF1 (>>) |
| GZMA → IFNB1 (>>) |
| GZMA → SLAMF1 (>>) |
| GZMA → EPYC (>>) |
| GZMA → MAB21L1 (>>) |
| GZMA → CD8A (>>) |
| GZMA → KLRD1 (>>) |
| GZMA → TRBC1///TRBC2///TRBV7-4///TRBV7-6///TRBV7-7///TRBV7-8 (>>) |
| GZMA → CDH1 (>>) |
| GZMA → KLRG1 (>>) |
| GZMA → CD27 (>>) |
| GZMA → TRAC///TRAJ17///TRAV20///TRD@///TRA@ (>>) |
| GZMA → ZKSCAN1 (>>) |
| GZMA → SEMA3G (>>) |
